DanishMed ApS: Financial statements 2025
CVR: 44471035
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
DanishMed ApS (CVR 44471035) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -6,282 and a net result of DKK -6,282 compared with DKK -26,300 the year before. Equity in the 2025 report amounted to DKK 7,418. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -6,282
- Profit/Loss
- DKK -6,282
- Equity
- DKK 7,418
- Total Assets
- DKK 7,418
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | -6 t. | -6 t. | 7 t. | - |
| 2024 | 0 | -34 t. | -26 t. | 14 t. | - |
Official annual report
How creditworthy is DanishMed ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
DanishMed ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -26,300.
About DanishMed ApS
DanishMed ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2023. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Company Health ApS and Youshape ApS. The management consists of Kenneth Edward Smith. The board consists of Hans Søndergaard Nielsen (chair), Erik Kilstrup Povlsen and Trygve Ibsen Bank. The company's owners include Erik Kilstrup Povlsen, SWAY SOLUTIONS ApS and LK Smith Holding ApS. In 2025, the company reported a gross profit of DKK -6,282 and a net result of DKK -6,282 compared with DKK -26,300 the year before. Equity in the 2025 report amounted to DKK 7,418.